EHS
EHS

STAT+: Scientists CRISPR patients’ own immune cells in bid to shrink hard-to-treat GI tumors



Last year, researchers at the University of Pennsylvania, led by immunotherapy pioneer Carl June, showed that it was safe and feasible to treat cancer patients with infusions of their own immune cells that had been edited with the technology known as CRISPR.

The trial was small, and the patients weren’t cured of their cancer. The study was designed only to test safety.

Continue to STAT+ to read the full story…

Source link

EHS
Back to top button